In hepatocellular carcinoma (HCC), METTL3 has been reported to promote tumor cell proliferation through the YTHDF2-dependent silencing of SOCS2, resulting in the overactivation of the JAK/STAT pathway [48]. The gene discussed is SOCS2; the disease is hepatocellular carcinoma.